The combination eliminates the need for two separate injections, reduces total injection volume, and ensures consistent dosing ratios optimized for synergistic effects
Product Attributes CAS # : 75921-69-6 Molecular Formula : C78H111N21O19 Sequence (AA) : Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 Molecular Weight : 1646.85 g/mol PubChem CID : 16132139 Half-Life : ~30-60 minutes (extended pigmentation effect lasts weeks) Synonyms : Afamelanotide, MT-I, MT-1, NDP-MSH, Scenesse, [Nle4, D-Phe7]-alpha-MSH Type : Synthetic research peptide (alpha-MSH analog, MC1R agonist) Research Focus : Skin Pigmentation & Photoprotection, Melanocortin Signaling Scientific References Afamelanotide for prevention of phototoxicity in patients with erythropoietic protoporphyria Human RCT | Regulatory Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo Human RCT Photoprotection by melanocortin 1 receptor agonists Animal | In vitro Afamelanotide: a melanocortin analogue for photoprotection Observational | Animal The melanocortin-1 receptor: red hair and beyond In vitro | Observational Melanocortin 1 receptor signaling and skin pigmentation In vitro | Animal Scenesse (afamelanotide) European Medicines Agency assessment report Regulatory | Human RCT Included In The Box Every product arrives in a premium, custom-designed PEPTIDE.Power box , engineered for convenience, hygiene, and safe storage in your refrigerator
Diabetes Care (2013) 36(1):418.10.2337/dc12-1128 85 ShinACamilleriMBusciglioIBurtonDSmithSAVellaAet alThe ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus
NAC may be beneficial for adults seeking additional antioxidant support, healthy liver function, and support for normal detoxification pathways
This genetic insightcombined with your lifestyle capacityhelps your care team set realistic expectations about treatment duration
